Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
14.22
0.02 (0.14%)
At close: Sep 26, 2025, 11:00 AM
0.14% (1D)
| Bid | 14.02 |
| Market Cap | 29.11M |
| Revenue (ttm) | 2.13K |
| Net Income (ttm) | -10.44M |
| EPS (ttm) | -8.88 |
| PE Ratio (ttm) | -1.6 |
| Forward PE | -2.55 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 14.29 |
| Volume | 8,103 |
| Avg. Volume (20D) | 32,088 |
| Open | 14.01 |
| Previous Close | 14.20 |
| Day's Range | 14.00 - 14.30 |
| 52-Week Range | 8.74 - 22.90 |
| Beta | 0.98 |
| Ex-Dividend Date | n/a |
About CVKD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVKD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVKD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+23.72%
Cadrenal Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
11 months ago
+17.97%
Cadrenal Therapeutics shares are trading higher after the company announced that is has raised gross proceeds of approximately $5.1 million through its at-the-market facility.
